So you’ve decided to include digital health devices in your trial. While that’s a great step to take as an organization, and an important step towards innovating the R&D process, it’s just the beginning.
You now have to select a device that will best suit the needs of both the trial and the patient and think through nuances with data collection and analysis. It’s easy to overlook some of the key items that need to be considered. And organizations do this all of the time because that’s not the core competency of drug developers (nor should it be).
The good news is you don’t have to go into this process blindly. According to a recent research report by Validic, 64 percent of pharma companies have already used digital health tech in trials. This means you can take advantage of the lessons learned from those that have gone before you. Here are 5 lessons learned, or things you should not do when integrating devices into trials.Read More On www.mobihealthnews.com
Categories Medtech & Devices